BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
fredun pharmaceuticals limited stock

Fredun Pharmaceuticals Limited Share Price

725 -13.59 (-1.83%)
Dec 13 2024 03:29 PM Pharmaceuticals NSE: FREDUN

Fredun Pharmaceuticals Limited Share Price Update

As of the latest trading session, Fredun Pharmaceuticals Limited share price is currently at 725, which is down by -13.59 from its previous closing. Today, the stock has fluctuated between 701.00 and 747.90. Over the past year, Fredun Pharmaceuticals Limited has achieved a return of -14.71 %. In the last month alone, the return has been 5.76 %. Read More...

Fredun Pharmaceuticals Limited Performance

Day Range

Low701.00 High747.90
729.65

52 Week Range

Low 650.00 High 1054.00
729.65

Fredun Pharmaceuticals Limited Share Price

539730

FREDUN

img img img img
No Data Available

Open Price

722.10

Prev. Close

738.60

Volume (Shares)

7410.00

Total traded value

53.09

Upper Circuit

886.30

Lower Circuit

590.90

Note: The current prices & values are delayed, Login to your account for live updates.

Fredun Pharmaceuticals Limited Fundamentals


(Standalone)

Market Cap (Cr) 342.90
PE Ratio (TTM) 19.38
Book Value / Share 278.44
Beta 0.66
ROE 14.34%
EPS (TTM) 37.64
Dividend Yield 0.10%
Net Profit Qtr (Cr) 4.27

Fredun Pharmaceuticals Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 106.89
Operating Expense 99.78
Net Profit 4.27
Net Profit Margin (%) 3.99
Earnings Per Share (EPS) 9.05
EBITDA 13.95
Effective Tax Rate (%) 43.53
Particulars JUN 2024 (Values in Cr)
Revenue 77.54
Operating Expense 73.28
Net Profit 4.13
Net Profit Margin (%) 5.32
Earnings Per Share (EPS) 8.79
EBITDA 10.48
Effective Tax Rate (%) 25.18
Particulars MAR 2024 (Values in Cr)
Revenue 117.21
Operating Expense 112.19
Net Profit 5.06
Net Profit Margin (%) 4.31
Earnings Per Share (EPS) 10.77
EBITDA 11.17
Effective Tax Rate (%) 13.35
Particulars DEC 2023 (Values in Cr)
Revenue 86.65
Operating Expense 81.25
Net Profit 4.22
Net Profit Margin (%) 4.87
Earnings Per Share (EPS) 8.99
EBITDA 10.52
Effective Tax Rate (%) 26.73
Particulars SEP 2023 (Values in Cr)
Revenue 81.48
Operating Expense 76.22
Net Profit 3.94
Net Profit Margin (%) 4.83
Earnings Per Share (EPS) 8.40
EBITDA 9.61
Effective Tax Rate (%) 31.71
Particulars MAR 2024 (Values in Cr)
Revenue 346.58
Operating Expense 327.62
Net Profit 15.62
Net Profit Margin (%) 4.50
Earnings Per Share (EPS) 33.32
EBITDA 38.90
Effective Tax Rate (%) 27.17
Particulars MAR 2023 (Values in Cr)
Revenue 274.34
Operating Expense 258.99
Net Profit 10.81
Net Profit Margin (%) 3.94
Earnings Per Share (EPS) 22.93
EBITDA 29.59
Effective Tax Rate (%) 38.26
Particulars MAR 2022 (Values in Cr)
Revenue 221.74
Operating Expense 217.48
Net Profit 6.34
Net Profit Margin (%) 2.85
Earnings Per Share (EPS) 14.29
EBITDA 15.43
Effective Tax Rate (%) 26.27
Particulars MAR 2021 (Values in Cr)
Revenue 131.55
Operating Expense 130.92
Net Profit 2.01
Net Profit Margin (%) 1.52
Earnings Per Share (EPS) 5.05
EBITDA 9.37
Effective Tax Rate (%) 37.07
Particulars MAR 2020 (Values in Cr)
Revenue 110.30
Operating Expense 110.78
Net Profit 1.90
Net Profit Margin (%) 1.72
Earnings Per Share (EPS) 4.77
EBITDA 8.78
Effective Tax Rate (%) 23.69
Particulars MAR 2024 (Values in Cr)
Book Value / Share 255.15
ROE % 14.34
ROCE % 16.95
Total Debt to Total Equity 0.88
EBITDA Margin 11.17
Particulars MAR 2023 (Values in Cr)
Book Value / Share 194.27
ROE % 13.15
ROCE % 17.43
Total Debt to Total Equity 0.85
EBITDA Margin 10.78
Particulars MAR 2022 (Values in Cr)
Book Value / Share 153.07
ROE % 11.41
ROCE % 12.90
Total Debt to Total Equity 0.83
EBITDA Margin 6.91
Particulars MAR 2021 (Values in Cr)
Book Value / Share 107.96
ROE % 4.76
ROCE % 9.34
Total Debt to Total Equity 0.88
EBITDA Margin 7.16
Particulars MAR 2020 (Values in Cr)
Book Value / Share 103.57
ROE % 4.73
ROCE % 10.16
Total Debt to Total Equity 0.67
EBITDA Margin 7.85
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.35
Total Assets 307.59
Total Liabilities 307.59
Total Equity 121.47
Share Outstanding 4699162
Price to Book Ratio 2.81
Return on Assets (%) 5.07
Return on Capital (%) 6.88
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.43
Total Assets 257.27
Total Liabilities 257.27
Total Equity 96.37
Share Outstanding 4532272
Price to Book Ratio 4.00
Return on Assets (%) 4.20
Return on Capital (%) 5.91
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.07
Total Assets 186.98
Total Liabilities 186.98
Total Equity 68.06
Share Outstanding 4432643
Price to Book Ratio 5.98
Return on Assets (%) 3.38
Return on Capital (%) 5.24
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.12
Total Assets 161.61
Total Liabilities 161.61
Total Equity 43.07
Share Outstanding 3989634
Price to Book Ratio 4.29
Return on Assets (%) 1.24
Return on Capital (%) 2.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 3.05
Total Assets 141.37
Total Liabilities 141.37
Total Equity 41.32
Share Outstanding 3989634
Price to Book Ratio 1.13
Return on Assets (%) 1.34
Return on Capital (%) 2.5
Particulars MAR 2024 (Values in Cr)
Net Income 15.62
Cash from Operations -0.43
Cash from Investing -7.63
Cash from Financing 5.99
Net change in Cash -2.08
Free Cash Flow 7.20
Particulars MAR 2023 (Values in Cr)
Net Income 10.75
Cash from Operations -14.40
Cash from Investing -9.40
Cash from Financing 25.17
Net change in Cash 1.36
Free Cash Flow -4.91
Particulars MAR 2022 (Values in Cr)
Net Income 6.31
Cash from Operations -2.38
Cash from Investing -4.14
Cash from Financing 7.46
Net change in Cash 0.94
Free Cash Flow 1.90
Particulars MAR 2021 (Values in Cr)
Net Income 2.01
Cash from Operations 0.16
Cash from Investing -1.38
Cash from Financing -0.71
Net change in Cash -1.93
Free Cash Flow 1.55
Particulars MAR 2020 (Values in Cr)
Net Income 2.34
Cash from Operations -10.61
Cash from Investing -1.49
Cash from Financing 13.72
Net change in Cash 1.59
Free Cash Flow -9.12
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 36.86 3.50 491.45 37.54 / 77.70
BLISS GVS PHARMA LTD 175.85 22.01 1.83 1852.87 92.25 / 179.65
CIPLA LTD 1447.35 25.32 4.12 116889.80 1192.85 / 1702.00
FERMENTA BIOTECH LIMITED 403.70 140.17 4.09 1188.13 145.00 / 440.00
GLAXOSMITHKLINE PHARMA LT 2254.45 47.63 22.83 38191.74 1668.20 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 64.13 55.77 10.90 491.45 37.54 / 77.70
AMRUTAJAN HEALTH LTD 749.90 45.61 7.28 2168.01 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6603.60 128.25 24.30 16509.00 4050.15 / 8139.85
BLISS GVS PHARMA LTD 175.85 22.93 1.80 1852.87 92.25 / 179.65

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 740.80
  • 26 Days 734.60
  • 10 Days 748.00
  • 50 Days 739.30
  • 12 Days 746.60
  • 100 Days 761.10
  • 20 Days 735.40
  • 200 Days 864.90
732.35
PIVOT
First Resistance 756.25
Second Resistance 773.90
Third Resistance 797.80
First Support 714.70
Second Support 690.80
Third Support 673.15
RSI 47.35
MACD 12.00
Commodity Channel Index (CCI) -18.09
ADX 23.64
Williams % R -71.74

Over 1 Month

down

5.76

Over 3 Months

down

-7.16

Over 6 Months

down

-20.53

Over 1 Year

down

-14.71

Over 3 Years

down

6.56

Over 5 Years

down

26.02

Fredun Pharmaceuticals Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Fredun Pharmaceuticals Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
49.48
Promoter Holdings
48.93
FII
0.0
DII
1.58
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Daulat Nariman Medhora Shareholding of Promoter and Promoter Group 1410898.0 29.88
Nariman Medhora Shareholding of Promoter and Promoter Group 719815.0 15.24
Nikhil Kishorchandra Vora Public Shareholding 301010.0 6.38
Fredun Nariman Medhora Shareholding of Promoter and Promoter Group 179672.0 3.81
Bank Of India Public Shareholding 75000.0 1.59
Arun Kumar Mukherjee Public Shareholding 67466.0 1.43

Fredun Pharmaceuticals Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-22 0.7 Final 2023-09-22 Equity shares 2021-09-16 0.7 Final 2021-09-18 Equity shares 2019-09-16 0.65 Final 2019-09-18 Equity shares 2018-09-18 0.6 Final 2018-09-21 Equity shares 2017-09-20 0.6 Final 2017-09-22 Equity shares 2016-04-11 0.6 Interim 2016-04-13 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Fredun Pharmaceuticals Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Fredun Pharmaceuticals Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Fredun Pharmaceuticals Ltd?

Answer Field

The share price of Fredun Pharmaceuticals Ltd for NSE is ₹ 0.00 and for BSE is ₹ 729.65.

What is the Market Cap of Fredun Pharmaceuticals Ltd?

Answer Field

The market cap of Fredun Pharmaceuticals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 3,42.90 Cr. as of now.

What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Fredun Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 1054.00 and ₹ 650.00.

How to Buy Fredun Pharmaceuticals Ltd share?

Answer Field

You can trade in Fredun Pharmaceuticals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Fredun Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -14.71%.

What is the Current Share Price of Fredun Pharmaceuticals Ltd?

Answer Field

Fredun Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 729.65 as on Dec 13 2024 03:29 PM.

What is the Market Cap of Fredun Pharmaceuticals Ltd Share?

Answer Field

The market cap of Fredun Pharmaceuticals Ltd for NSE ₹ 0.0 & for BSE ₹ 3,42.90 as on Dec 13 2024 03:29 PM.

What is the P/E Ratio of Fredun Pharmaceuticals Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM the price-to-earnings (PE) ratio for Fredun Pharmaceuticals Ltd share is 19.38.

What is the PB ratio of Fredun Pharmaceuticals Ltd Share?

Answer Field

As on Dec 13 2024 03:29 PM, the price-to-book (PB) ratio for Fredun Pharmaceuticals Ltd share is 278.44.

How to Buy Fredun Pharmaceuticals Ltd Share?

Answer Field

You can trade in Fredun Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Fredun Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Fredun Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Fredun Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text
loader